Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;18(9):1468-71.
doi: 10.3201/eid1809.111731.

Prevalence of oral human papillomavirus infection among youth, Sweden

Juan Du  1 , Cecilia Nordfors, Andreas Ahrlund-Richter, Michal Sobkowiak, Mircea Romanitan, Anders Näsman, Sören Andersson, Torbjörn Ramqvist, Tina Dalianis
Affiliations

Prevalence of oral human papillomavirus infection among youth, Sweden

Juan Du et al. Emerg Infect Dis. 2012 Sep.

Abstract

Human papillomavirus (HPV) causes cervical, head, and neck cancers. We studied 483 patients at a youth clinic in Stockholm, Sweden, and found oral HPV prevalence was 9.3% and significantly higher for female youth with than without cervical HPV infection (p = 0.043). Most oral HPV types matched the co-occurring cervical types.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of human papillomavirus (HPV) types in oral samples from 24 female youth with oral HPV infection, Stockholm, Sweden. The 4 most common HPV types were high-risk types HPV16 (2.9%, 95% CI 1.7%–4.8%), HPV59 (1.4%, 95% CI 0.7%–3.0%), and HPV51 (1.2%, 95% CI 0.6%–2.7%) and low-risk type HPV42 (1.0%, 95% CI 0.4%–2.4%).
Figure 2
Figure 2
Prevalence of human papillomavirus (HPV) types in cervical samples from 24 female youth with oral HPV infection, Stockholm, Sweden. The 4 most common types were high-risk types HPV16 (37.9%, 95% CI 31.0%–45.3%); HPV52 (16.1%, 95% CI 11.4%–22.3%), and HPV51 (15.5%, 95% CI 10.9%–21.6%) and low-risk type HPV42 (17.8%, 95% CI 12.9%–24.2%).
See this image and copyright information in PMC

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. 10.1002/ijc.25516 - DOI - PubMed
    1. Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis. 2010;16:1671–7. - PMC - PubMed
    1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65. 10.1136/jcp.55.4.244 - DOI - PMC - PubMed
    1. Diaz ML. Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine. Int J Womens Health. 2010;1:119–29. - PMC - PubMed
    1. Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, et al. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15–23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis. 2011;43:115–21. 10.3109/00365548.2010.526957 - DOI - PubMed

Publication types

LinkOut - more resources